Emerging therapies for atrial fibrillation: is the paradigm shifting?
نویسندگان
چکیده
منابع مشابه
Nonpharmacological Therapies for Atrial Fibrillation
1Division of Cardiology (Heart Rhythm Service), Kingston General Hospital, Queen’s University, Kingston, ON, Canada K7L 2V7 2Cardiac Arrhythmia and Electrophysiology Unit, Department of Cardiology, Hospital Virgen de la Salud, 45004 Toledo, Spain 3Department of Cardiovascular Medicine, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium 4Southlake Heart Rhythm Program, Division of Cardiology, Southlake...
متن کاملEmerging drugs for atrial fibrillation
Atrial fibrillation (AF) is associated with excess morbidity and mortality, and is the most common reason for arrhythmia-related hospitalization [1]. As a result of an aging population, the prevalence of AF is expected to rise over the next several decades, and as many as 6 million individuals may be affected by the year 2050 in the USA alone [2]. Greater awareness regarding the changing epidem...
متن کاملMinimally Invasive Surgical Therapies for Atrial Fibrillation
Atrial fibrillation is the most common sustained arrhythmia and is associated with significant risks of thromboembolism, stroke, congestive heart failure, and death. There have been major advances in the management of atrial fibrillation including pharmacologic therapies, antithrombotic therapies, and ablation techniques. Surgery for atrial fibrillation, including both concomitant and stand-alo...
متن کاملEvolution of Curative Therapies For Atrial Fibrillation
Atrial fibrillation (AF) is one of the most common arrhythmias seen in clinical practice. The incidence of AF increases with age and is seen in up to 8.9% of individuals greater than 80 years of age.1 Although many treatment modalities are available for AF, curative therapy has recently become possible for some patients with atrial fibrillaton. This is partly due to the complexity and incomplet...
متن کاملEmerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Interventional Cardiac Electrophysiology
سال: 2010
ISSN: 1383-875X,1572-8595
DOI: 10.1007/s10840-010-9472-x